Mavenclad
Active substance: cladribine
cladribine
Centralised EU authorisationActive
Marketing holder: Merck Europe B.V.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 11 |
|
| US 7 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-6439-7724-b903-bed338150f2c,01a120c3-660d-77b4-bc8f-c106adb83eab,01a120c3-760c-73a4-8a34-7d2ecc5a6593,01a120c3-e8c2-74eb-8591-ad728d15550b,01a120c3-f2d5-767c-932f-1c43678b646d;count=8 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8f45-7f36-ad80-183c6e84143a,01a1208c-e981-7aa9-8b84-19168b552883,01a1208e-3be3-7900-a41a-dd23c4297d3f,01a1208e-8f9b-7a24-9ee2-d0d5ac787ac8,01a1208e-97a0-78f5-bbbb-204d0da8ec46;count=7 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/004230
- Registration status
- Active
- ATC code
- L04AA40
- product · EMA · EMEA/H/C/004230 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004230 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004230 · Verified 2026-10-09